KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Liabilities and Shareholders Equity (2016 - 2025)

Edwards Lifesciences (EW) has 17 years of Liabilities and Shareholders Equity data on record, last reported at $13.7 billion in Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 4.92% year-over-year to $13.7 billion; the TTM value through Dec 2025 reached $53.5 billion, up 16.61%, while the annual FY2025 figure was $13.7 billion, 4.92% up from the prior year.
  • Liabilities and Shareholders Equity reached $13.7 billion in Q4 2025 per EW's latest filing, up from $13.3 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $13.7 billion in Q4 2025 and bottomed at $7.2 billion in Q1 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $10.1 billion, with a median of $9.2 billion recorded in 2023.
  • Peak YoY movement for Liabilities and Shareholders Equity: dropped 2.47% in 2022, then soared 39.43% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $8.5 billion in 2021, then decreased by 2.47% to $8.3 billion in 2022, then grew by 12.91% to $9.4 billion in 2023, then skyrocketed by 39.43% to $13.1 billion in 2024, then grew by 4.92% to $13.7 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $13.7 billion in Q4 2025, $13.3 billion in Q3 2025, and $13.5 billion in Q2 2025.